Polygon Management »

Karyopharm Therapeutics shares owned by Polygon Management

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Polygon Management from 13F filings

Historical chart of Polygon Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Polygon Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Polygon Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $574k 103k 5.57

More positions owned by Polygon Management

Uipath Cl A (PATH)
Kolibri Global Energy Com New (KGEI)
Warner Bros Discovery Com Ser A (WBD)
Workiva Com Cl A (WK)
Lyft Cl A Com (LYFT)
Sprinklr Cl A (CXM)
Autolus Therapeutics Spon Ads (AUTL)
Celldex Therapeutics Com New (CLDX)
Axsome Therapeutics (AXSM)
Arrowhead Pharmaceuticals (ARWR)
Nektar Therapeutics Com New (NKTR)
Annexon (ANNX)
Pharvaris N V (PHVS)
Alkermes SHS (ALKS)
Agios Pharmaceuticals (AGIO)

View all positions for Polygon Management

Top funds holding Karyopharm Therapeutics

Ikarian Capital
Commodore Capital
RA Capital Management
T. Rowe Price Investment Management
Goldman Sachs Group
Catalio Capital Management
Affinity Asset Advisors
Susquehanna International
Boothbay Fund Management
Squadron Capital Management
Vanguard Capital Management
Jane Street
Vanguard Group
Millennium Management
Citadel Advisors

View all funds holding Karyopharm Therapeutics